Pay in 4 interest-free payments of $6.88 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
This compound is frequently used in studies exploring transcriptional regulators of energy output and endurance, particularly in muscle tissue
The first method used a Basic Local Alignment Search Tool Nucleotide (BLASTn
efficacy goal was not met Claim 300500 mcg per day Published human support No controlled human SubQ study Community support Commonly reported How it should be described Community research amount Claim Start at 300 mcg and increase after four weeks Published human support No Community support Commonly reported How it should be described Anecdotal step-up model Claim 8- or 16-week SubQ cycle Published human support No Community support Commonly reported How it should be described Community timeline only Claim Use beyond 24 weeks Published human support No Community support Scattered reports How it should be described Unsupported by published long-term evidence AOD-9604 is not an FDA-approved drug
Not in newborns
Precision Medicine (Bellmore, NY)
US$ 26.23
US$ 23.71
US$ 22.49
US$ 27.78
US$ 24.04
US$ 22.64
US$ 25.11
US$ 26.92
US$ 29.40
US$ 26.37
